全文获取类型
收费全文 | 4168篇 |
免费 | 181篇 |
国内免费 | 257篇 |
专业分类
4606篇 |
出版年
2024年 | 10篇 |
2023年 | 51篇 |
2022年 | 71篇 |
2021年 | 66篇 |
2020年 | 76篇 |
2019年 | 121篇 |
2018年 | 141篇 |
2017年 | 73篇 |
2016年 | 74篇 |
2015年 | 78篇 |
2014年 | 232篇 |
2013年 | 299篇 |
2012年 | 182篇 |
2011年 | 241篇 |
2010年 | 160篇 |
2009年 | 174篇 |
2008年 | 167篇 |
2007年 | 243篇 |
2006年 | 200篇 |
2005年 | 216篇 |
2004年 | 134篇 |
2003年 | 163篇 |
2002年 | 134篇 |
2001年 | 105篇 |
2000年 | 99篇 |
1999年 | 91篇 |
1998年 | 90篇 |
1997年 | 79篇 |
1996年 | 81篇 |
1995年 | 82篇 |
1994年 | 70篇 |
1993年 | 59篇 |
1992年 | 39篇 |
1991年 | 34篇 |
1990年 | 38篇 |
1989年 | 35篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 25篇 |
1985年 | 40篇 |
1984年 | 45篇 |
1983年 | 40篇 |
1982年 | 22篇 |
1981年 | 32篇 |
1980年 | 22篇 |
1979年 | 37篇 |
1978年 | 19篇 |
1977年 | 18篇 |
1976年 | 13篇 |
1973年 | 9篇 |
排序方式: 共有4606条查询结果,搜索用时 0 毫秒
91.
Valizadeh M Schenk G Nash K Oddie GW Guddat LW Hume DA de Jersey J Burke TR Hamilton S 《Archives of biochemistry and biophysics》2004,424(2):154-162
Purple acid phosphatases are metal-containing hydrolases. While their precise biological role(s) is unknown, the mammalian enzyme has been linked in a variety of biological circumstances (e.g., osteoporosis) with increased bone resorption. Inhibition of the human enzyme is a possible strategy for the treatment of bone-resorptive diseases such as osteoporosis. Previously, we determined the crystal structure of pig purple acid phosphatase to 1.55A and we showed that it is a good model for the human enzyme. Here, a study of the pH dependence of its kinetic parameters showed that the pig enzyme is most efficient at pH values similar to those encountered in the osteoclast resorptive space. Based on the observation that phosphotyrosine-containing peptides are good substrates for pig purple acid phosphatase, peptides containing a range of phosphotyrosine mimetics were synthesized. Kinetic analysis showed that they act as potent inhibitors of mammalian and plant purple acid phosphatases, with the best inhibitors exhibiting low micromolar inhibition constants at pH 3-5. These compounds are thus the most potent organic inhibitors yet reported for the purple acid phosphatases. 相似文献
92.
遗传标记与数量性状基因间连锁关系的分析 总被引:2,自引:0,他引:2
本文讨论标记基因与数量性状主基因连锁关系的一般分析方法,包括重组值的估计和有关遗传假设的测验。并以我们水稻遗传试验中两个具有互补和重叠作用的卷叶基因和一个矮秆基因试验结果的分析为例作了较详细的示范。 相似文献
93.
通过生物素与亲和素-酶复合物系统或地高辛与抗地高辛-酶复合物系统可把酶间接标记到探针上.Renz等通过不同的化学方法直接把酶标记到探针上[1~3].耐热性碱性磷酸酯酶FD-TAP(thermostablealkalinephosphatase)具有耐... 相似文献
94.
Hsu EC Lin YC Hung CS Huang CJ Lee MY Yang SC Ting LP 《Journal of biomedical science》2007,14(6):731-744
Summary Protein-tyrosine phosphatase PTPN3 is a membrane-associated non-receptor protein-tyrosine phosphatase. PTPN3 contains a N-terminal
FERM domain, a middle PDZ domain, and a C-terminal phosphatase domain. Upon co-expression of PTPN3, the level of human hepatitis
B viral (HBV) RNAs, 3.5 kb, 2.4/2.1 kb, and 0.7 kb transcribed from a replicating HBV expression plasmid is significantly
reduced in human hepatoma HuH-7 cells. When the expression of endogenous PTPN3 protein is diminished by specific small interfering
RNA, the expression of HBV genes is enhanced, indicating that the endogenous PTPN3 indeed plays a suppressive role on HBV
gene expression. PTPN3 can interact with HBV core protein. The interaction is mediated via the PDZ domain of PTPN3 and the
carboxyl-terminal last four amino acids of core. Either deletion of PDZ domain of PTPN3 or substitution of PDZ ligand in core
has no effect on PTPN3-mediated suppression. These results clearly show that the interaction of PTPN3 with core is not required
for PTPN3 suppressive effect. Mutation of 359serine and 835serine of 14-3-3β binding sites to alanine, which slightly reduces the interaction with 14-3-3β, does not influence the PTPN3
effect. In contrast, mutation of the invariant 842cysteine residue in phosphatase domain to serine, which makes the phosphatase activity inactive, does not change its subcellular
localization and interaction with core or 14-3-3β, but completely abolishes PTPN3-mediated suppression. Furthermore, deletion
of FERM domain does not affect the phosphatase activity or interaction with 14-3-3β, but changes the subcellular localization
from cytoskeleton-membrane interface to cytoplasm and nucleus, abolishes binding to core, and diminishes the PTPN3 effect
on HBV gene expression. Taken together, these results demonstrate that the phosphatase activity and FERM domain of PTPN3 are
essential for its suppression of HBV gene expression.
En-Chi Hsu, Yen-Cheng Lin have equal contributions to this work. 相似文献
95.
小麦珠心细胞衰退过程酸性磷酸酶的超微细胞化学定位(英文) 总被引:1,自引:0,他引:1
采用磷酸铅盐沉淀技术对小麦( Triticum aestivum L.) 珠心细胞衰退过程进行了酸性磷酸酶的超微细胞化学定位研究。结果显示,在未有明显衰退迹象的一些珠心细胞中,酸性磷酸酶只出现在细胞核轻微凝聚的染色质上。随珠心细胞衰退程度的逐渐增大,其衰退特征越来越明显,酸性磷酸酶依次在细胞质中较小液泡、细胞壁、线粒体、质体以及内质网等结构上出现活性反应。紧连胚囊的珠心细胞衰退程度最大,细胞严重变形,酸性磷酸酶定位于细胞绝大部分结构中,但此时变形的细胞核则无酸性磷酸酶活性反应。研究结果表明,小麦珠心细胞的衰退过程中,酸性磷酸酶存在一个有规律的变化,支持珠心细胞的衰退是属于细胞程序性死亡类型的观点 相似文献
96.
Akihiko Masui Nobuaki Fujiwara Masahiro Takagi Tadayuki Imanaka 《Biotechnology Techniques》1999,13(11):813-815
Enzymatic decomposition of gelatin layers on X-ray films and repeated utilization of enzyme for potential industrialization were investigated using thermostable alkaline protease from the alkaliphilic Bacillus sp. B21-2. The decomposition of gelatin layers at 50 °C with the mutant enzyme (Ala187 was replaced by Pro) was higher than those of the wild-type and other mutant enzymes. In the repeated experiment for every 60 min (20 U ml–1, 50 °C), the mutant enzyme could be satisfactorily used five times while three times for the wild-type enzyme. 相似文献
97.
It has been over 35 years since the first identification of phosphorylation of myosin light chains in skeletal and cardiac muscle. Yet only in the past few years has the role of these phosphorylations in cardiac dynamics been more fully understood. Advances in this understanding have come about with further evidence on the control mechanisms regulating the level of phosphorylation by kinases and phosphatases. Moreover, studies clarifiying the role of light chain phosphorylation in short and long term control of cardiac contractility and as a factor in cardiac remodeling have improved our knowledge. Especially important in these advances has been the use of gain and loss of function approaches, which have not only testedthe role of kinases and phosphatases, but also the effects of loss of RLC phosphorylation sites. Major conclusions from these studies indicate that (i) two negatively-charged post-translational modifications occupy the ventricular RLC N-terminus, with mouse RLC being doubly phosphorylated (Ser 14/15), and human RLC being singly phosphorylated (Ser 15) and singly deamidated(Asn14/16 to Asp); (ii)a distinct cardiac myosin light kinase (cMLCK) and a unique myosin phosphatase targeting peptide (MYPT2) control phosphoryl group transfer;and (iii) ablation of RLC phosphorylationdecreases ventricular power, lengthens the duration of ventricular ejection, and may also modify other sarcomeric proteins (e.g., troponin I) as substrates for kinases and/or phosphatases. A long term effect of low levels of RLC phosphorylation in mouse models also involves remodeling of the heart with hypertrophy, depressed contractility, and sarcomeric disarray. Data demonstrating altered levels of RLC phosphorylation in comparisons of samples from normal and stressed human hearts indicate the significance of these findings in translational medicine. 相似文献
98.
Kawano M Ariyoshi W Iwanaga K Okinaga T Habu M Yoshioka I Tominaga K Nishihara T 《Biochemical and biophysical research communications》2011,(4):1222-580
Objectives
Bone morphogenetic protein-2 (BMP-2) is expected to be utilized to fill bone defects and promote healing of fractures. However, it is unable to generate an adequate clinical response for use in bone regeneration. Recently, it was reported that glycosaminoglycans, including heparin, heparan sulfate, keratan sulfate, dermatan sulfate, chondroitin-4-sulfate, chondroitin-6-sulfate, and hyaluronic acid (HA), regulate BMP-2 activity, though the mechanism by which HA regulates osteogenic activities has not been fully elucidated. The aim of this study was to investigate the effects of HA on osteoblast differentiation induced by BMP-2.Materials and methods
Monolayer cultures of osteoblastic lineage MG63 cells were incubated with BMP-2 and HA for various time periods. To determine osteoblastic differentiation, alkaline phosphatase (ALP) activity in the cell lysates was quantified. Phosphorylation of Smad 1/5/8, p38, and ERK proteins was determined by Western blot analysis. To elucidate the nuclear translocation of phosphorylated Smad 1/5/8, stimulated cells were subjected to immunofluorescence microscopy. To further elucidate the role of HA in enhancement of BMP-2-induced Smad signaling, mRNA expressions of the BMP-2 receptor antagonists noggin and follistatin were detected using real-time RT-PCR.Results
BMP-2-induced ALP activation, Smad 1/5/8 phosphorylation, and nuclear translocation were up-regulated when MG63 cells were cultured with both BMP-2 and HA. Western blot analysis revealed that phosphorylation of ERK protein was diminished by HA. Furthermore, the mRNA expressions of noggin and follistatin induced by BMP-2 were preferentially blocked by HA.Conclusions
These results indicate that HA enhanced BMP-2 induces osteoblastic differentiation in MG63 cells via down-regulation of BMP-2 antagonists and ERK phosphorylation. 相似文献99.
Maki Yamagata Keisuke Obara Akio Kihara 《Biochemical and biophysical research communications》2011,(4):786
In eukaryotes, autophagy is a conserved protein degradation system that degrades cytoplasmic components by encompassing them with double-membrane structures, called autophagosomes, and delivering them to the lytic compartments of vacuoles/lysosomes. Certain Atg proteins are known to be involved in autophagy, yet the identity and function of lipid molecules involved remain largely unknown. We investigated the involvement of sphingolipids in autophagy using Saccharomyces cerevisiae. Inhibiting synthesis of the simplest complex sphingolipid, inositol phosphorylceramide (IPC), resulted in reduced autophagic activities. Similar results were obtained using myriocin, an inhibitor of the first step in sphingolipid synthesis. Our results indicate that sphingolipids, especially IPC, are required for autophagy. Inhibition of sphingolipid synthesis had no effect on formation of Atg12-Atg5 or Atg8-phosphatidylethanolamine conjugates, on maturation of vacuolar proteases, or on formation of the pre-autophagosomal structure (PAS). These results suggest that sphingolipids are not involved in the cellular signaling that leads to formation of the PAS, but may be involved in the process of autophagosome formation. 相似文献
100.
Muhonen P Tennilä T Azhayeva E Parthasarathy RN Janckila AJ Väänänen HK Azhayev A Laitala-Leinonen T 《化学与生物多样性》2007,4(5):858-873
Short interfering RNA (siRNA) molecules with good gene-silencing properties are needed for drug development based on RNA interference (RNAi). An initial step in RNAi is the activation of the RNA-induced silencing complex RISC, which requires degradation of the sense strand of the siRNA duplex. Although various chemical modifications have been introduced to the antisense strand, modifications to the Argonaute2 (Ago2) cleavage site in the sense strand have, so far, not been described in detail. In this work, novel 2'-F-purine modifications were introduced to siRNAs, and their biological efficacies were tested in cells stably expressing human tartrate-resistant acid phosphatase (TRACP). A validated siRNA that contains both purine and pyrimidine nucleotides at the putative Ago2 cleavage site was chemically modified to contain all possible combinations of 2'-fluorinated 2'-deoxypurines and/or 2'-deoxypyrimidines in the antisense and/or sense strands. The capacity of 2'-F-modified siRNAs to knock down their target mRNA and protein was studied, together with monitoring siRNA toxicity. All 2'-F-modified siRNAs resulted in target knockdown at nanomolar concentrations, despite their high thermal stability. These experiments provide the first evidence that RISC activation not only allows 2'-F modifications at the sense-strand cleavage site, but also increase the biological efficacy of modified siRNAs in vitro. 相似文献